WHAT ARE INDIRECT COSTS IN NEURODEGENERATIVE DISEASES? A METHODOLOGICAL REVIEW

Author(s)

Costa N, Deruemaux-Burel H, Molinier L
University Hospital of Toulouse, Toulouse, France

OBJECTIVES: Neurodegenerative diseases (NDs) refer to a group of diseases that affect brain cells. Alzheimer disease (AD), Parkinson disease (PD), Amyotrophique Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) are the most prevalent NDs. NDs cause a substantial economic burden worldwide and indirect costs are an important component of total costs. This study aims to review relevant papers to characterize the different components of indirect costs and to identify the weight of indirect costs on total costs in different NDs. METHODS: A systematic bibliographic search was performed on an international medical literature database (MEDLINE). All studies which assessed the social economic burden and indirect costs of different NDs were selected. Indirect costs were characterized into several types (i.e. sick leave, presenteeism, early retirement, premature death, reduction in working hours, informal care time) and into several valuation (i.e. Human Capital Approach, Friction Cost Method, Willingness To Pay). RESULTS:

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PRM28

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Multiple Diseases, Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×